Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01588431
Title Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ahmad Wehbe
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Therapy and Research Center at UTHSCSA San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field